Aerovate Therapeutics
AVTE
#8978
Rank
S$79.9 M
Marketcap
$2.77
Share price
1.67%
Change (1 day)
-84.74%
Change (1 year)

Aerovate Therapeutics (AVTE) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : S$22.52 M

According to Aerovate Therapeutics's latest financial reports the company's total liabilities are S$22.52 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aerovate Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31S$11.47 M188.87%
2021-12-31S$3.97 M-83.36%
2020-12-31S$23.87 M148.07%
2019-12-31S$9.62 M